FTSE Russell Cello Health (0961V)
2020年8月5日 - 1:30AM
RNSを含む英国規制内ニュース (英語)
TIDMCLL
RNS Number : 0961V
FTSE Russell
04 August 2020
Cello Health (UK): Constituent Deletion
Changes in FTSE UK Index Series
04 August 2020
Subject to court sanctioning the scheme of arrangement in relation to the cash offer for Cello
Health (UK, constituent) by Pharma Value Demonstration Bidco Ltd (non constituent), please
see details of affected indexes and effective dates below:
Index Effective From
Start of Trading
FTSE AIM All-Share Index 11 August 2020
For further information please contact FTSE Russell Client Services at info@ftserussell.com
or call: Australia +1800 653 680
Hong Kong +852 2164 3333
Japan +81 3 4563 6346
London +44 (0) 20 7866 1810
New York +1866 551 0617
Alternatively please visit our website at www.ftserussell.com
Terms of Use | Copyright (c) 2020 FTSE Russell
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
FTSFLFSITRISIII
(END) Dow Jones Newswires
August 04, 2020 12:30 ET (16:30 GMT)
Cello Health (LSE:CLL)
過去 株価チャート
から 4 2024 まで 5 2024
Cello Health (LSE:CLL)
過去 株価チャート
から 5 2023 まで 5 2024
Real-Time news about Cello Health Plc (ロンドン証券取引所): 0 recent articles
その他のCello Health Plcニュース記事